We are live on ! Find out more
BC

Birchview Capital Portfolio holdings

AUM $176M
1-Year Est. Return 95.04%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+95.04%
3 Year Est. Return
+233.14%
5 Year Est. Return
+280.2%
10 Year Est. Return
+1,023.63%
AUM
$123M
AUM Growth
-$5.11M
Cap. Flow
-$4.27M
Cap. Flow %
-3.48%
Top 10 Hldgs %
68.23%
Holding
60
New
2
Increased
7
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
DCGO icon
DocGo
DCGO
+$1.17M
2
CHRS icon
Coherus Oncology
CHRS
+$394K
3
AXSM icon
Axsome Therapeutics
AXSM
+$336K
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$248K
5
AXDX
Accelerate Diagnostics
AXDX
+$158K

Top Sells

Rank Stock Value
1
IMGN
Immunogen Inc
IMGN
+$5.57M
2
CYTK icon
Cytokinetics
CYTK
+$1.16M
3
LQDA icon
Liquidia Corp
LQDA
+$139K

Sector Composition

Rank Sector Weight
1 Healthcare 94.27%
2 Energy 5.73%
3 Consumer Staples 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CABA icon
51
Cabaletta Bio
CABA
$439M
$171K 0.14%
10,000
– –
GOSS icon
52
Gossamer Bio
GOSS
$66.5M
$163K 0.13%
138,176
– –
VTYX
53
DELISTED
Ventyx Biosciences
VTYX
$158K 0.13%
28,800
– –
LQDA icon
54
Liquidia Corp
LQDA
$7.67B
$148K 0.12%
10,000
-10,000
-50% -$139K
TSVT
55
DELISTED
2seventy bio
TSVT
$106K 0.09%
19,833
– –
BCRX icon
56
BioCryst Pharmaceuticals
BCRX
$2.37B
$102K 0.08%
20,000
– –
IFRX icon
57
InflaRx
IFRX
$256M
$77K 0.06%
50,000
– –
CERO
58
DELISTED
CERo Therapeutics
CERO
$39.8K 0.03%
+6
New +$67.1K
YTEN
59
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$7.13K 0.01%
781
– –
IMGN
60
DELISTED
Immunogen Inc
IMGN
– –
-188,000
Closed -$5.57M
1 2
3

Similar funds

RWA
Resolute Wealth Advisor Findlay, Ohio $176M AUM
BAM
Boyar Asset Management New York $176M AUM 20.04% 1-Year Est. Return
TIM
Tevis Investment Management Plano, Texas $176M AUM 18.14% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $176M AUM
PFA
Providence Financial Advisors Overland Park, Kansas $175M AUM
DAM
Draper Asset Management Smithtown, New York $176M AUM 37.45% 1-Year Est. Return
AF
Align Financial Hermantown, Minnesota $176M AUM
OA
Oceanside Advisors Mount Pleasant, South Carolina $175M AUM 17.96% 1-Year Est. Return

Birchview Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Birchview Capital held 60 positions worth $123M, down 4% from $128M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Birchview Capital withdrew a net $4.27M in Q1 2024, closing 1 position and reducing 2 holdings. Its most notable exit was Immunogen Inc, an estimated $5.57M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 95% a quarter earlier, followed by Energy and Consumer Staples.

Against the trend, Birchview Capital opened a new position in Axsome Therapeutics worth $319K.

  • Birchview Capital's largest Q1 2024 buy was Axsome Therapeutics: 4,000 shares worth $319K.
  • Birchview Capital added most to DocGo in Q1 2024, an estimated $1.17M increase.
  • Birchview Capital's biggest Q1 2024 reduction was Cytokinetics, cutting an estimated $1.16M.
  • Birchview Capital fully exited Immunogen Inc in Q1 2024, selling an estimated $5.57M.
  • Birchview Capital's ten largest holdings make up 68% of its $123M portfolio in Q1 2024.
  • Birchview Capital opened 2 new positions and closed 1 in Q1 2024.
  • Birchview Capital's portfolio value fell 4% quarter-over-quarter to $123M.

Based on Birchview Capital's 13F filing for Q1 2024, filed 14 May 2024.